Larvol Delta - Faridoxorubicin-AVA6000-Phase-1b-cohort-demonstrates-clinically-meaningful-tumor-shrinkage-in-patients-with-salivary-gland-cancers

faridoxorubicin (AVA6000) - Avacta

https://www.globenewswire.com/news-release/2025/12/17/3206840/0/en/Faridoxorubicin-AVA6000-Phase-1b-cohort-demonstrates-clinically-meaningful-tumor-shrinkage-in-patients-with-salivary-gland-cancers.html

Dec 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next